Simtuzumab Completed Phase 2 Trials for Fibrosis, Liver Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01452308Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis